Role of deep learning in early detection of COVID-19: Scoping review. Review uri icon

Overview

abstract

  • BACKGROUND: Since the onset of the COVID-19 pandemic, the world witnessed disruption on an unprecedented scale affecting our daily lives including but not limited to healthcare, business, education, and transportation. Deep Learning (DL) is a branch of Artificial intelligence (AI) applications, the recent growth of DL includes features that could be helpful in fighting the COVID-19 pandemic. Utilizing such features could support public health efforts. OBJECTIVE: Investigate the literature available in the use of DL technology to support dealing with the COVID-19 crisis. We summarize the literature that uses DL features to analyze datasets for the purpose of a quick COVID-19 detection. METHODS: This review follows PRISMA Extension for Scoping Reviews (PRISMA-ScR). We have scanned the most two commonly used databases (IEEE, ACM). Search terms were identified based on the target intervention (DL) and the target population (COVID-19). Two authors independently handled study selection and one author assigned for data extraction. A narrative approach is used to synthesize the extracted data. RESULTS: We retrieved 53 studies and after passing through PRISMA excluding criteria, only 17 studies are considered in this review. All studies used deep learning for detection of COVID-19 cases in early stage based on different diagnostic modalities. Convolutional Neural Network (CNN) and Transfer Learning (TL) were the most commonly used techniques. CONCLUSION: The included studies showed that DL techniques has significant impact on early detection of COVID-19 with high accuracy rate. However, most of the proposed methods are still in development and not tested in a clinical setting. Further investigation and collaboration are required from the research community and healthcare professionals in order to develop and standardize guidelines for use of DL in the healthcare domain.

publication date

  • July 30, 2021

Identity

PubMed Central ID

  • PMC8321699

Scopus Document Identifier

  • 85087668610

Digital Object Identifier (DOI)

  • 10.1016/j.cmpbup.2021.100025

PubMed ID

  • 34345877

Additional Document Info

volume

  • 1